{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:07:17Z","timestamp":1791403637067,"version":"4.3.3"},"reference-count":93,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2004,10,1]],"date-time":"2004-10-01T00:00:00Z","timestamp":1096588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2004,10]]},"DOI":"10.1016\/j.pbb.2004.07.013","type":"journal-article","created":{"date-parts":[[2004,10,4]],"date-time":"2004-10-04T19:02:24Z","timestamp":1096916544000},"page":"279-290","source":"Crossref","is-referenced-by-count":40,"title":["Bidirectional effects of benzodiazepine binding site ligands in the elevated plus-maze: differential antagonism by flumazenil and \u03b2-CCt"],"prefix":"10.1016","volume":"79","author":[{"given":"Miroslav M.","family":"Savi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dragan I.","family":"Obradovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad D.","family":"Ugre\u0161i\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyuan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dubravko R.","family":"Bokonji\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2004.07.013_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0893-133X(98)00052-9","article-title":"Regional differences in the inhibition of mouse in vivo [3H]Ro 15-1788 binding reflect selectivity for alpha 1 versus alpha 2 and alpha 3 subunit-containing GABAA receptors","volume":"20","author":"Atack","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib2","first-page":"291","article-title":"International Union of Pharmacology: XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2004.07.013_bib3","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/0024-3205(85)90047-5","article-title":"Interactions between the benzodiazepine receptor antagonist Ro 15-1788 (flumazepil) and the inverse agonist beta-CCE: behavioral studies with squirrel monkeys","volume":"36","author":"Barrett","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2004.07.013_bib4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/0031-9384(95)02224-4","article-title":"Illumination has no effect on rats' behavior in the elevated plus-maze","volume":"59","author":"Becker","year":"1996","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0166-4328(01)00291-1","article-title":"Measuring normal and pathological anxiety-like behaviour in mice: a review","volume":"125","author":"Belzung","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2004.07.013_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0091-3057(87)90006-2","article-title":"Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light\/dark choice situation","volume":"28","author":"Belzung","year":"1987","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00008877-200004000-00004","article-title":"Beta-CCT, a selective BZ-omega1 receptor antagonist, blocks the anti-anxiety but not the amnesic action of chlordiazepoxide in mice","volume":"11","author":"Belzung","year":"2000","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0166-4328(01)00396-5","article-title":"Behavioral profile of rats submitted to session 1-session 2 in the elevated plus-maze during diurnal\/nocturnal phases and under different illumination conditions","volume":"132","author":"Bertoglio","year":"2002","journal-title":"Behav. Brain Res.."},{"key":"10.1016\/j.pbb.2004.07.013_bib9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0091-3057(02)00710-4","article-title":"Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze","volume":"72","author":"Bertoglio","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib10","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S0091-3057(02)00958-9","article-title":"Anxiolytic effects of ethanol and phenobarbital are abolished in test-experienced rats submitted to the elevated plus maze","volume":"73","author":"Bertoglio","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0166-4328(02)00018-9","article-title":"Emotional changes related to age in rat\u2014a behavioral analysis","volume":"133","author":"Boguszewski","year":"2002","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2004.07.013_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0166-4328(01)00180-2","article-title":"Vibrissal sense is not the main sensory modality in rat exploratory behavior in the elevated plus-maze","volume":"122","author":"Cardenas","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2004.07.013_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.2174\/1568026023393552","article-title":"GABA-A receptor complex and memory processes","volume":"2","author":"Chapouthier","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.pbb.2004.07.013_bib14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1021\/jm9904349","article-title":"GABA-Activated ligand gated ion channels: medicinal chemistry and molecular biology","volume":"43","author":"Chebib","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2004.07.013_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0149-7634(97)00058-4","article-title":"Biological bases of anxiety","volume":"22","author":"Clement","year":"1998","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2004.07.013_bib16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/BF02245598","article-title":"Effects of benzodiazepine receptor partial inverse agonists in the elevated plus maze test of anxiety in the rat","volume":"121","author":"Cole","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib17","first-page":"710","article-title":"Bz1 receptor subtype specific ligands. synthesis and biological properties of \u03b2CCt, a Bz1 receptor subtype specific antagonist","volume":"5","author":"Cox","year":"1995","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.pbb.2004.07.013_bib18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0091-3057(94)90472-3","article-title":"Ethopharmacological analysis of rat behavior on the elevated plus-maze","volume":"49","author":"Cruz","year":"1994","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib19","first-page":"401","article-title":"Anxiogenic effects of the intraamygdala injection of flumazenil, a benzodiazepine receptor antagonist","volume":"7","author":"Da Cunha","year":"1992","journal-title":"Funct. Neurology"},{"key":"10.1016\/j.pbb.2004.07.013_bib20","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0091-3057(02)01009-2","article-title":"Lack of midazolam-induced anxiolysis in the plus-maze Trial 2 is dependent on the length of Trial 1","volume":"74","author":"Dal-Col","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0091-3057(98)00220-2","article-title":"Behavioral effects of diazepam in the murine plus-maze: flumazenil antagonism of enhanced head dipping but not the disinhibition of open-arm avoidance","volume":"62","author":"Dalvi","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib22","first-page":"335","article-title":"Common mechanisms underlying the proconflict effects of corticotropin-releasing factor, a benzodiazepine inverse agonist and electric foot-shock","volume":"262","author":"De Boer","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2004.07.013_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1471-4159.2001.00551.x","article-title":"Prevalence between different alpha subunits performing the benzodiazepine binding sites in native heterologous GABA(A) receptors containing the alpha2 subunit","volume":"79","author":"del Rio","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.07.013_bib24","first-page":"649","article-title":"Zolpidem, a novel nonbenzodiazepine hypnotic: I. Neuropharmacological and behavioral effects","volume":"237","author":"Depoortere","year":"1986","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2004.07.013_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0091-3057(95)02171-X","article-title":"The influence of open arm ledges and maze experience in the elevated plus-maze","volume":"54","author":"Fernandes","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/026988110101500203","article-title":"Interactions between LY354740, a group II metabotropic agonist and the GABA(A)-benzodiazepine receptor complex in the rat elevated plus-maze","volume":"15","author":"Ferris","year":"2001","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF02244232","article-title":"A theory of benzodiazepine dependence that can explain whether flumazenil will enhance or reverse the phenomena","volume":"101","author":"File","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(83)90170-2","article-title":"Interactions of ethyl-beta-carboline-3-carboxylate and Ro 15-1788 with CGS 8216 in an animal model of anxiety","volume":"39","author":"File","year":"1983","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2004.07.013_bib29","first-page":"198","article-title":"The anxiogenic action of FG 7142 in the social interaction test is reversed by chlordiazepoxide and Ro 15-1788 but not by CGS 8216","volume":"271","author":"File","year":"1984","journal-title":"Arch. Int. Pharmacodyn. Ther."},{"key":"10.1016\/j.pbb.2004.07.013_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00310505","article-title":"Intrinsic actions of the benzodiazepine receptor antagonist Ro 15-1788","volume":"88","author":"File","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib31","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/cne.903590111","article-title":"GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits","volume":"359","author":"Fritschy","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pbb.2004.07.013_bib32","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s002130051157","article-title":"Naltrexone potentiates the anxiolytic effects of chlordiazepoxide in rats exposed to novel environments","volume":"147","author":"Frussa-Filho","year":"1999","journal-title":"Psychopharmacology"},{"issue":"4","key":"10.1016\/j.pbb.2004.07.013_bib33","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1523\/JNEUROSCI.17-04-01505.1997","article-title":"A five minute experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphe nucleus","volume":"17","author":"Gonzalez","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2004.07.013_bib34","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1046\/j.1460-9568.1998.00375.x","article-title":"Stimulation of benzodiazepine receptors in the dorsal hippocampus and median raphe reveals differential GABAergic control in two animal tests of anxiety","volume":"10","author":"Gonzalez","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2004.07.013_bib35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0091-3057(95)00141-I","article-title":"The elevated plus-maze is not sensitive to the effect of stressor controllability in rats","volume":"52","author":"Grahn","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0376-6357(93)90026-N","article-title":"Some critical determinants of the behavior of rats in the elevated plus-maze","volume":"29","author":"Griebel","year":"1993","journal-title":"Behav. Proc."},{"key":"10.1016\/j.pbb.2004.07.013_bib37","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF02246664","article-title":"The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands","volume":"124","author":"Griebel","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib38","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0028-3908(96)00080-9","article-title":"Further evidence for differences between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands in murine models of \u201cstate\u201d and \u201ctrait\u201d anxiety","volume":"35","author":"Griebel","year":"1996","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib39","first-page":"560","article-title":"The mouse defense test battery: evaluation of the effects of non-selective and BZ-1 (omega1) selective, benzodiazepine receptor ligands","volume":"7","author":"Griebel","year":"1996","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1177\/026988119801200405","article-title":"Limited anxiolytic-like effects of non-benzodiazepine hypnotics in rodents","volume":"12","author":"Griebel","year":"1998","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s002130051108","article-title":"New evidence that the pharmacological effects of benzodiazepine receptor ligands can be associated with activities at different BZ (omega) receptor subtypes","volume":"146","author":"Griebel","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib42","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","article-title":"A review of the validity and variability of the elevated plus-maze as an animal model of anxiety","volume":"54","author":"Hogg","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1021\/jm990341r","article-title":"Pharmacophore\/receptor models for GABA(A)\/BzR subtypes (alpha1beta3gamma2, alpha5beta3gamma2, and alpha6beta3gamma2) via a comprehensive ligand-mapping approach","volume":"43","author":"Huang","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.pbb.2004.07.013_bib44","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1476-5381.1995.tb13310.x","article-title":"Interaction of beta-carboline on GABAA receptors","volume":"114","author":"Im","year":"1995","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/syn.10086","article-title":"Conditioned-fear stress increases Fos expression in monoaminergic and GABAergic neurons of the locus coeruleus and dorsal raphe nuclei","volume":"45","author":"Ishida","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.pbb.2004.07.013_bib46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/0361-9230(87)90104-3","article-title":"Bidirectional effects of beta-carbolines and benzodiazepines on cognitive processes","volume":"19","author":"Jensen","year":"1987","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2004.07.013_bib47","first-page":"87","article-title":"Are drug effects in the elevated plus-maze dependent on the baseline level of fear?","volume":"5","author":"Jones","year":"1994","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0031-9384(00)00388-7","article-title":"Influence of circadian phase and test illumination on pre-clinical models of anxiety","volume":"72","author":"Jones","year":"2001","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02244836","article-title":"Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies","volume":"114","author":"Jones","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib50","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/sj.npp.1300239","article-title":"The reinforcing properties of alcohol are mediated by GABA(A1) receptors in the ventral pallidum","volume":"28","author":"June","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0028-3908(03)00340-X","article-title":"Differential actions of diazepam and zolpidem in basolateral and central amygdala nuclei","volume":"46","author":"Kang-Park","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib52","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0006-8993(02)04082-9","article-title":"Compartmentation of alpha 1 and alpha 2 GABA(A) receptor subunits within rat extended amygdala: implications for benzodiazepine action","volume":"964","author":"Kaufmann","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2004.07.013_bib53","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.alcohol.2003.08.007","article-title":"SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats","volume":"32","author":"Knapp","year":"2004","journal-title":"Alcohol"},{"key":"10.1016\/j.pbb.2004.07.013_bib54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0028-3908(02)00174-0","article-title":"GABA(A) receptor alpha-1 subunit deletion alters receptor subtype assembly, pharmacological and behavioral responses to benzodiazepines and zolpidem","volume":"43","author":"Kralic","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib55","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0028-3908(91)90021-3","article-title":"Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice","volume":"30","author":"Lee","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib56","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0091-3057(79)90304-6","article-title":"A synthetic non-benzodiazepine ligand for benzodiazepine receptors: a probe for investigating neuronal substrates of anxiety","volume":"11","author":"Lippa","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib57","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib58","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s002139900354","article-title":"Comparison of benzodiazepines and the non-benzodiazepine agents zolpidem and zaleplon with respect to anxiolytic action as measured by increases in hypertonic NaCl-solution drinking in rats","volume":"149","author":"Lobarinas","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib59","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","article-title":"Molecular and neuronal substrate for the selective attenuation of anxiety","volume":"290","author":"Low","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.pbb.2004.07.013_bib60","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00002826-199506000-00002","article-title":"The effects of flumazenil in neuropsychiatric disorders","volume":"18","author":"Malizia","year":"1995","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib61","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0091-3057(89)90349-3","article-title":"Inhibition of sleep and benzodiazepine receptor binding by a beta-carboline derivative","volume":"34","author":"Martin","year":"1989","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib62","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1016\/S0924-977X(02)80105-5","article-title":"The role of GABA-A receptors subtypes in the effects of benzodiazepines","volume":"12","author":"McKernan","year":"2002","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib63","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","article-title":"Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype","volume":"3","author":"McKernan","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2004.07.013_bib64","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0301-0082(03)00087-X","article-title":"The neurobiology and control of anxious states","volume":"70","author":"Millan","year":"2003","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.pbb.2004.07.013_bib65","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1124\/jpet.300.1.2","article-title":"A new benzodiazepine pharmacology","volume":"300","author":"M\u00f6hler","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2004.07.013_bib66","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s002130050303","article-title":"Flumazenil blockade of anxiety following ethanol withdrawal in rats","volume":"131","author":"Moy","year":"1997","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib67","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/BF01291890","article-title":"Benzodiazepine-GABAA receptor complex ligands in two models of anxiety","volume":"104","author":"Nazar","year":"1997","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.pbb.2004.07.013_bib68","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0091-3057(88)90463-7","article-title":"Proconvulsant and \u2018anxiogenic\u2019 effects of n-butyl beta carboline-3-carboxylate, an endogenous benzodiazepine binding inhibitor from brain","volume":"30","author":"Novas","year":"1988","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib69","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(98)00603-7","article-title":"Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands","volume":"358","author":"Olivier","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib70","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0091-3057(86)90552-6","article-title":"Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat","volume":"24","author":"Pellow","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0014-2999(90)90375-G","article-title":"Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics","volume":"187","author":"Perrault","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib72","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0306-4522(00)00442-5","article-title":"GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain","volume":"101","author":"Pirker","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2004.07.013_bib73","first-page":"253","article-title":"The effects of flumazenil, Ro 15-4513 and beta-CCM on the behaviour of control and stressed mice in the plus-maze test","volume":"48","author":"Pokk","year":"1997","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib74","first-page":"691","article-title":"Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents","volume":"39","author":"Puia","year":"1991","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib75","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF00175795","article-title":"Behavioral differences in an elevated plus-maze: correlation between anxiety and decreased number of GABA and benzodiazepine receptors in mouse cerebral cortex","volume":"337","author":"Rago","year":"1988","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0166-4328(96)00164-7","article-title":"A multiple-test study of anxiety-related behaviours in six inbred rat strains","volume":"85","author":"Ramos","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2004.07.013_bib77","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S0165-6147(00)01773-9","article-title":"Anxiolytic-like action of diazepam: which GABA(A) receptor subtype is involved?","volume":"22","author":"Reynolds","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2004.07.013_bib78","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0149-7634(96)00058-9","article-title":"Anxiety, defence and the elevated plus-maze","volume":"21","author":"Rodgers","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2004.07.013_bib79","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","article-title":"Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety","volume":"52","author":"Rodgers","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib80","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0091-3057(95)00190-8","article-title":"Ethopharmacological analysis of the effects of putative \u2018anxiogenic\u2019 agents in the mouse elevated plus-maze","volume":"52","author":"Rodgers","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.07.013_bib81","first-page":"247","article-title":"Zolpidem, triazolam, and diazepam decrease distress vocalizations in mouse pups: differential antagonism by flumazenil and beta-carboline-3-carboxylate-t-butyl ester (beta-CCt)","volume":"297","author":"Rowlett","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2004.07.013_bib82","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.pharmtox.44.101802.121429","article-title":"Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics","volume":"44","author":"Rudolph","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.pbb.2004.07.013_bib83","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","article-title":"Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes","volume":"401","author":"Rudolph","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2004.07.013_bib84","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02246973","article-title":"Role of benzodiazepine receptors located in the dorsal periaqueductal grey of rats in anxiety","volume":"110","author":"Russo","year":"1993","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib85","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/BF00174367","article-title":"The discriminative stimulus properties of zolpidem, a novel imidazopyridine hypnotic","volume":"89","author":"Sanger","year":"1986","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib86","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/0024-3205(84)90464-8","article-title":"beta-Carboline-3-carboxylate-t-butyl ester: a selective BZ1 benzodiazepine receptor antagonist","volume":"35","author":"Shannon","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2004.07.013_bib87","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0896-6273(90)90224-4","article-title":"The effect of subunit composition of rat brain GABAA receptors on channel function","volume":"5","author":"Sigel","year":"1990","journal-title":"Neuron"},{"key":"10.1016\/j.pbb.2004.07.013_bib88","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0361-9230(87)90099-2","article-title":"Modulation of anxiety by beta-carbolines and other benzodiazepine receptor ligands: relationship of pharmacological to biochemical measures of efficacy","volume":"19","author":"Stephens","year":"1987","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2004.07.013_bib89","first-page":"965","article-title":"beta-Carboline gamma-aminobutyric acidA receptor inverse agonists modulate gamma-aminobutyric acid via the loreclezole binding site as well as the benzodiazepine site","volume":"48","author":"Stevenson","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib90","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/BF02245647","article-title":"Effects of DN-2327, a new anxiolytic, diazepam and buspirone on exploratory activity of the rat in an elevated plus-maze","volume":"104","author":"Wada","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2004.07.013_bib91","first-page":"437","article-title":"Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA\/benzodiazepine receptors","volume":"44","author":"Wafford","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2004.07.013_bib92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.ps.38.020187.000333","article-title":"New designs in analysis of variance","volume":"38","author":"Wilcox","year":"1987","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.pbb.2004.07.013_bib93","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0166-4328(03)00107-4","article-title":"Anxiety-related behavior and densities of glutamate, GABAA, acetylcholine and serotonin receptors in the amygdala of seven inbred mouse strains","volume":"145","author":"Yilmazer-Hanke","year":"2003","journal-title":"Behav. Brain Res."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704002709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704002709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T08:24:50Z","timestamp":1549182290000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305704002709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":93,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,10]]}},"alternative-id":["S0091305704002709"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2004.07.013","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}